NovoCure Ltd (NVCR) insider trading.
In Q3 2026, insiders at NovoCure Ltd reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 4
- Last filed
- 2026-07-01
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Danziger Asaf | Director | 1 | 0 | 0 |
| Leonard Frank X | Officer · Chief Executive Officer | 1 | 0 | 0 |
| Ben Arye Barak | Officer · General Counsel | 1 | 0 | 0 |
| Puri Michal Nath | Officer · Chief Human Resources Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Danziger Asaf | A (A) | 268 | $11.15 | 416,742 | Form 4 |
| 2026-06-30 | Leonard Frank X | A (A) | 1,905 | $11.15 | 461,425 | Form 4 |
| 2026-06-30 | Ben Arye Barak | A (A) | 1,299 | $11.15 | 243,752 | Form 4 |
| 2026-06-30 | Puri Michal Nath | A (A) | 1,905 | $11.15 | 203,227 | Form 4 |
Transaction codes in this quarter
Get NVCR insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1645113&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · NVCR company page · NovoCure Ltd on SEC.gov
Questions
Are insiders buying or selling NovoCure Ltd (NVCR)?
In Q3 2026, insiders at NovoCure Ltd reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these NovoCure Ltd insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/nvcr.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.